Fresenius Medical Care AG - Laporan Laba Rugi (TTM)

Fresenius Medical Care AG
IT ˙ BIT ˙ DE0005785802
€ 41.50 ↓ -0.52 (-1.24%)
2025-09-04
BAHAGING PRESYO
Laporan Laba Rugi (TTM)

Laporan Laba Rugi Fresenius Medical Care AG menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.

Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.

2020
09-30
2020
12-31
2021
03-31
2021
06-30
2021
09-30
2021
12-31
2022
03-31
2022
06-30
2022
09-30
2022
12-31
2023
03-31
2023
06-30
2023
09-30
2023
12-31
2024
03-31
2024
06-30
2024
09-30
2024
12-31
2025
03-31
2025
06-30
Revenue 18,039 17,859 17,581 17,344 17,372 17,619 17,957 18,393 19,048 19,398 19,554 19,622 19,463 19,454 19,474 19,415 19,239 19,336 19,493 19,518
Change (%) -1.00 -1.55 -1.35 0.16 1.42 1.92 2.43 3.56 1.84 0.80 0.35 -0.82 -0.05 0.10 -0.30 -0.91 0.50 0.81 0.13
% of Revenue 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00
Cost Of Sales 12,422 12,322 12,226 12,119 12,238 12,846 12,911 13,386 14,064 14,504 14,685 14,802 14,656 14,529 14,524 14,496 14,403 14,579 14,726 14,703
Change (%) -0.81 -0.78 -0.88 0.99 4.96 0.51 3.68 5.07 3.13 1.24 0.80 -0.98 -0.87 -0.03 -0.19 -0.64 1.22 1.01 -0.15
% of Revenue 68.86 68.99 69.54 69.87 70.45 72.91 71.90 72.78 73.84 74.77 75.10 75.43 75.31 74.68 74.58 74.67 74.86 75.40 75.54 75.33
Gross Operating Profit 5,617 5,537 5,355 5,225 5,134 4,773 5,046 5,008 4,984 4,894 4,869 4,821 4,806 4,925 4,950 4,919 4,836 4,757 4,767 4,815
Change (%) -1.42 -3.29 -2.42 -1.76 -7.02 5.72 -0.76 -0.47 -1.81 -0.50 -0.99 -0.30 2.47 0.50 -0.62 -1.69 -1.64 0.22 1.00
% of Revenue 31.14 31.01 30.46 30.13 29.55 27.09 28.10 27.22 26.16 25.23 24.90 24.57 24.69 25.32 25.42 25.33 25.14 24.60 24.46 24.67
SG&A 2,991 2,966 2,868 2,986 3,011 2,773 3,091 3,018 3,104 3,170 3,163 3,180 3,156 3,196 3,190 3,186 3,148 3,143 3,118 3,138
Change (%) -0.83 -3.32 4.14 0.82 -7.91 11.46 -2.34 2.85 2.13 -0.25 0.55 -0.74 1.26 -0.20 -0.12 -1.18 -0.18 -0.79 0.66
% of Revenue 16.58 16.61 16.31 17.22 17.33 15.74 17.21 16.41 16.30 16.34 16.17 16.21 16.22 16.43 16.38 16.41 16.36 16.25 15.99 16.08
R&D 190 194 197 198 205 221 222 225 234 229 235 236 228 232 224 212 199 183 179 172
Change (%) 1.88 1.41 0.77 3.76 7.46 0.47 1.53 4.05 -2.44 2.66 0.75 -3.57 1.73 -3.43 -5.18 -6.12 -7.99 -2.35 -4.17
% of Revenue 1.05 1.09 1.12 1.14 1.18 1.25 1.24 1.22 1.23 1.18 1.20 1.21 1.17 1.19 1.15 1.09 1.04 0.95 0.92 0.88
OpEx 15,603 15,481 15,290 15,303 15,455 15,715 16,228 16,732 17,382 17,860 18,038 18,085 18,048 17,930 17,896 17,820 17,613 17,797 17,933 17,938
Change (%) -0.78 -1.24 0.09 0.99 1.68 3.27 3.10 3.89 2.75 1.00 0.26 -0.20 -0.66 -0.19 -0.42 -1.16 1.04 0.77 0.02
% of Revenue 86.49 86.69 86.97 88.23 88.96 89.19 90.37 90.97 91.25 92.07 92.25 92.16 92.73 92.17 91.90 91.79 91.55 92.04 92.00 91.90
Operating Income 2,436 2,378 2,291 2,041 1,917 1,904 1,729 1,662 1,666 1,538 1,515 1,537 1,414 1,524 1,578 1,595 1,626 1,539 1,560 1,581
Change (%) -2.40 -3.63 -10.92 -6.07 -0.69 -9.21 -3.86 0.25 -7.68 -1.46 1.45 -8.02 7.73 3.59 1.04 1.97 -5.34 1.32 1.34
% of Revenue 13.51 13.31 13.03 11.77 11.04 10.81 9.63 9.03 8.75 7.93 7.75 7.84 7.27 7.83 8.10 8.21 8.45 7.96 8.00 8.10
Interest Expense -429 -410 -388 -368 -357 -354 -345 -347 -355 -360 -372 -392 -413 -425 -434 -432 -417 -407 -399 -392
Change (%) -4.39 -5.28 -5.14 -3.04 -1.00 -2.30 0.33 2.45 1.41 3.18 5.48 5.44 2.76 2.17 -0.37 -3.41 -2.50 -2.00 -1.63
% of Revenue -2.38 -2.30 -2.21 -2.12 -2.06 -2.01 -1.92 -1.88 -1.86 -1.86 -1.90 -2.00 -2.12 -2.18 -2.23 -2.23 -2.17 -2.11 -2.05 -2.01
Net Income 1,330 1,164 1,131 998 918 969 878 806 763 673 602 596 450 499 484 530 659 538 618 656
Change (%) -12.43 -2.90 -11.71 -8.06 5.62 -9.45 -8.14 -5.33 -11.78 -10.54 -1.13 -24.47 10.92 -3.09 9.65 24.27 -18.37 14.92 6.19
% of Revenue 7.37 6.52 6.43 5.76 5.28 5.50 4.89 4.38 4.01 3.47 3.08 3.04 2.31 2.57 2.48 2.73 3.43 2.78 3.17 3.36

Source: Capital IQ

Other Listings
GB:FMED
GB:0H9X € 41.78
AT:FME
DE:FME € 41.95
BG:FME
CH:FME
US:FMCQF
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista